SciBase: Interim report

The second quarter in figures The second quarter in figures The first half-year in figures Important events during the quarter Important events after the end of the period This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on August19, 2025 . This interim report has not been...
Comunicato Precedente

next
Comunicato Successivo

next

The second quarter in figures

The first half-year in figures

Important events during the quarter

Important events after the end of the period

This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on August19, 2025.

This interim report has not been subject to review by the Company's auditors

This report, together with previously published interim reports, can be found in its entirety on the company's website: http://investors.scibase.se/en/reports-and-presentations

Contact person:
Michael Colérus, CFO, +46 70 341 34 72

For additional information, please contact:
Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected]

Certified Advisor (CA):
DNB Carnegie Investment Bank AB (publ) Phone: +46 (0)73 856 42 65 E-mail: [email protected]

About SciBase:

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/interim-report,c4219521

The following files are available for download:

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/scibase-interim-report-302533194.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;